Filip Djordjevic
Research Assistant
Working groups

Background
Filip joined Burnet Institute in 2019 on the Disease Elimination and Behaviours and Health Risks programs. He will be conducting research on Eliminating Hepatitis C cohort study as well as policy related to take-home naloxone in Australia.
Qualifications
- 2018: Masters of Public Health, University of Melbourne
- 2013: BA (Honours), Swinburne
- 2012: Bachelor of Social Science, Swinburne
Burnet publications
View 7 moreFeasibility and acceptability of multiple methods of recording injecting drug use episode data among people who inject drugs in Melbourne, Australia: a pilot evaluation study protocol
BMJ Open
Filip Djordjevic et al
The eliminate hepatitis C (EC) experience study: baseline characteristics of a cohort of people who inject drugs in Melbourne, Australia
BMJ Open
Jack Gunn et al
The feasibility of a drug consumption room in the Australian Capital Territory
Drug and Alcohol Review
Amy Kirwan et al
Current projects

Methamphetamine and injecting drug use cohort studies: MIXMAX
MIXMAX is the largest active cohort study of people who use drugs in Australia. It combines 2 pre-existing studies: SuperMIX and VMAX.

Methamphetamine use in Melbourne and rural Victoria: the VMAX cohort study
The VMAX cohort study follows 850 people who use methamphetamine recruited from metropolitan Melbourne and 3 regions of rural Victoria.

Injecting drug use in Melbourne: SuperMIX cohort study
The largest and longest-running active cohort study of people who inject drugs in Australia (since 2008).